Clinical Trial

Amylin-Induced Migraine Attacks Without Aura

Name: Amylin-Induced Migraine Attacks Without Aura — clinical trial record (NCT07340788)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Not Yet Recruiting

View on ClinicalTrials.gov →

Summary

Pramlintide is a peptide analogue of human amylin which is a vasoactive signaling molecule involved in the pathogenesis of migraine. This study investigates whether pramlintide induces migraine attacks without aura in people with migraine without aura.

Trial Details

NCT Number	NCT07340788
Lead Sponsor	Danish Headache Center
Conditions	Headache Disorders, Primary, Headache Disorders, Brain Diseases, Nervous System Diseases, Central Nervous System Diseases, Neurologic Manifestations, Signs and Symptoms, Pathological Conditions, Signs and Symptoms +10 more
Enrollment	21 participants
Start Date	2026-02
Primary Completion	2028-10-30 (estimated)
Study Completion	2028-10-30 (estimated)
Updated on ClinicalTrials.gov	2026-01-14